Touchstone International Medical Science Co., Ltd. (688013.SS)
CNY 19.66
(-0.61%)
CNY 19.66
(-0.61%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 46.43 Million CNY | 24.69% |
| 2022 | 44.11 Million CNY | 55.22% |
| 2021 | 28.42 Million CNY | -17.26% |
| 2020 | 34.35 Million CNY | -23.91% |
| 2019 | 45.14 Million CNY | 89.67% |
| 2018 | 23.8 Million CNY | 74.34% |
| 2017 | 13.65 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 18.63 Million CNY | 49.16% |
| 2024 Q3 | 11.3 Million CNY | -19.76% |
| 2024 Q1 | 12.49 Million CNY | -36.09% |
| 2023 Q3 | 7.06 Million CNY | -55.62% |
| 2023 FY | 55 Million CNY | 24.69% |
| 2023 Q4 | 19.55 Million CNY | 176.63% |
| 2023 Q2 | 15.92 Million CNY | 27.79% |
| 2023 Q1 | 12.46 Million CNY | 40.73% |
| 2022 Q3 | 15.17 Million CNY | 63.71% |
| 2022 Q2 | 9.27 Million CNY | 28.68% |
| 2022 Q1 | 7.2 Million CNY | 10.93% |
| 2022 FY | 44.11 Million CNY | 55.22% |
| 2022 Q4 | 8.85 Million CNY | -41.66% |
| 2021 Q1 | 14.6 Million CNY | 82.31% |
| 2021 Q4 | 6.49 Million CNY | -41.97% |
| 2021 FY | 28.42 Million CNY | -17.26% |
| 2021 Q3 | 11.19 Million CNY | -11.08% |
| 2021 Q2 | 12.58 Million CNY | -13.81% |
| 2020 Q3 | 11.14 Million CNY | 16.75% |
| 2020 Q1 | 5.65 Million CNY | -25.65% |
| 2020 Q2 | 9.54 Million CNY | 68.8% |
| 2020 FY | 34.35 Million CNY | -23.91% |
| 2020 Q4 | 8.01 Million CNY | -28.11% |
| 2019 FY | 45.14 Million CNY | 89.67% |
| 2019 Q3 | 14.14 Million CNY | -5.71% |
| 2019 Q2 | 15 Million CNY | 78.59% |
| 2019 Q1 | 8.39 Million CNY | 0.0% |
| 2019 Q4 | 7.6 Million CNY | -46.23% |
| 2018 FY | 23.8 Million CNY | 74.34% |
| 2017 FY | 13.65 Million CNY | 0.0% |